{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:12:54Z","timestamp":1782515574766,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.jns.2011.11.002","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:02:25Z","timestamp":1323216145000},"page":"41-47","source":"Crossref","is-referenced-by-count":49,"title":["Impact of complications and comorbidities on treatment costs and health-related quality of life of patients with Parkinson's disease"],"prefix":"10.1016","volume":"314","author":[{"given":"Jan-Philipp","family":"Bach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Klotsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Spottke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Dodel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"Wittchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2011.11.002_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.euroneuro.2005.04.007","article-title":"Prevalence and incidence of Parkinson's disease in Europe","volume":"15","author":"von Campenhausen","year":"2005","journal-title":"Eur. J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.jns.2011.11.002_bb0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jns.2011.11.002_bb0015","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/mds.21171","article-title":"Parkinson's disease and working capacity","volume":"21","author":"Martikainen","year":"2006","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.jns.2011.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/mds.21030","article-title":"Time of loss of employment in Parkinson's disease","volume":"21","author":"Schrag","year":"2006","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.jns.2011.11.002_bb0025","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.43.11.2227","article-title":"Risk factors for nursing home placement in advanced Parkinson's disease","volume":"43","author":"Goetz","year":"1993","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jns.2011.11.002_bb0205","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.euroneuro.2010.08.002","article-title":"Cost of ilness and care in Parkinson's disease: An evaluation in six countries","volume":"21","author":"von Campenhausen","year":"2011","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jns.2011.11.002_bb0035","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00115-009-2671-y","article-title":"Direct costs for Parkinson's treatment in private neurology practices in Berlin","volume":"80","author":"Ehret","year":"2009","journal-title":"Nervenarzt"},{"issue":"9","key":"10.1016\/j.jns.2011.11.002_bb0040","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20999","article-title":"Economic burden or Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China","volume":"21","author":"Wang","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jns.2011.11.002_bb0045","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00115-003-1582-6","article-title":"Analyse der direkten Kosten in der Parkinson-Therapie","volume":"74","author":"Keller","year":"2003","journal-title":"Nervenarzt"},{"issue":"1\u20132","key":"10.1016\/j.jns.2011.11.002_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jns.2006.05.030","article-title":"Quality of life and depression in Parkinson's disease","volume":"248","author":"Schrag","year":"2006","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jns.2011.11.002_bb0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/0891988709351833","article-title":"Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD study","volume":"23","author":"Riedel","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"2","key":"10.1016\/j.jns.2011.11.002_bb0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00415-008-0720-2","article-title":"Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD)","volume":"255","author":"Riedel","year":"2008","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jns.2011.11.002_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.jns.2011.11.002_bb0070","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2011.11.002_bb0075","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","article-title":"Frequency of dementia, depression, and other neuropsychiatric symptoms in 1449 outpatients with Parkinson's disease","volume":"257","author":"Riedel","year":"2010","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2011.11.002_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2011.11.002_bb0085","series-title":"Recent developments in Parkinson's disease","first-page":"153","article-title":"Unified Parkinson's disease rating scale","author":"Fahn","year":"1987"},{"key":"10.1016\/j.jns.2011.11.002_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state: a practical method for grading the mental state of patients by the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.jns.2011.11.002_bb0215","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders\u2014Text revision. 4 ed. Washington, DC: American Psychiatric Association 2000"},{"key":"10.1016\/j.jns.2011.11.002_bb0100","series-title":"SIDAM\u2014Strukturiertes Interview f\u00fcr die Diagnose einer Demenz vom Alzheimer Typ, der Multiinfarkt- (oder vaskul\u00e4ren) Demenz und Demnzen anderer \u00c4tiologien nach DSM-III-R, DSM-IV und ICD-10","author":"Zaudig","year":"1996"},{"key":"10.1016\/j.jns.2011.11.002_bb0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale, designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jns.2011.11.002_bb0110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQuol: a new facility for the measurement of health-related quality of life","volume":"16","author":"Group","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.jns.2011.11.002_bb0220","unstructured":"Bundesverband der pharmazeutischen Industrie. Rote Liste. Weinheim: Rote Liste Verlag 2009."},{"issue":"23","key":"10.1016\/j.jns.2011.11.002_bb0120","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1002\/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P","article-title":"Analysis of cost data in randomized trials: an application of the non-parametric bootstrap","volume":"19","author":"Barber","year":"2000","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.jns.2011.11.002_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2165\/00019053-199813050-00002","article-title":"The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data","volume":"13","author":"Desgagne","year":"1998","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.jns.2011.11.002_bb0225","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10198-003-0182-5","article-title":"A single European currency for EQ-5D health states. Results from a six-country study","volume":"4","author":"Greiner","year":"2003","journal-title":"Eur J Health Econ"},{"issue":"10","key":"10.1016\/j.jns.2011.11.002_bb0135","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s00115-006-2150-7","article-title":"Prospective study of the direct and indirect costs of idiopathic Parkinson's disease","volume":"77","author":"Dengler","year":"2006","journal-title":"Nervenarzt"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2011.11.002_bb0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1468-1331.2005.01197.x","article-title":"Cost of Parkinson's disease in Europe","volume":"12","author":"Lindgren","year":"2005","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.jns.2011.11.002_bb0230","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00019053-199814030-00006","article-title":"The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis","volume":"14","author":"Dodel","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jns.2011.11.002_bb0155","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00415-005-0784-1","article-title":"Pharmacotherapy of Parkinson's disease in Germany","volume":"252","author":"M\u00f6ller","year":"2005","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.jns.2011.11.002_bb0165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00023210-200822070-00003","article-title":"Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease","volume":"22","author":"Gallagher","year":"2008","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.jns.2011.11.002_bb0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.22060","article-title":"Initiating levodopa\/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study","volume":"68","author":"Stocchi","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2011.11.002_bb0180","series-title":"Leitlinien f\u00fcr die Diagnostik und Therapie in der Neurologie","article-title":"Parkinson-Syndrome: Diagnostik und Therapie","author":"Eggert","year":"2008"},{"issue":"12","key":"10.1016\/j.jns.2011.11.002_bb0235","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-2008-1038293","article-title":"Depression in Parkinson's disease. Part 1: epidemiology, signs and symptoms, pathophysiology and diagnosis","volume":"76","author":"Storch","year":"2008","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"10.1016\/j.jns.2011.11.002_bb0190","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","article-title":"Non-recognition of depression and other non-motor symptoms in Parkinson's disease","volume":"8","author":"Shulman","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1016\/j.jns.2011.11.002_bb0195","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.20555","article-title":"Antidepressant studies in Parkinson's disease: a review and meta-analysis","volume":"20","author":"Weintraub","year":"2005","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.jns.2011.11.002_bb0200","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1742-1241.2008.01869.x","article-title":"Diagnosis and management of Parkinson's disease dementia","volume":"62","author":"Poewe","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jns.2011.11.002_bb0240","author":"Deuschl"},{"issue":"12","key":"10.1016\/j.jns.2011.11.002_bb0245","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/mds.23878","article-title":"Projected numbers of people with movement disorders in the years 2030 and 2050","volume":"26","author":"Bach","year":"2011","journal-title":"Mov Disord"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1100654X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1100654X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T01:20:03Z","timestamp":1588814403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1100654X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0022510X1100654X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.11.002","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}